Clinical Trial Update: The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) clinical trial is recruiting to evaluate a bioartificial liver therapy using hiHep cells in patients after extensive hepatectomy for re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Bioartificial liver therapy using hiHep cells (hiHep cells)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Hepatoma Resectable | EARLY_Phase 1 | Status: RECRUITING